N-[1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)ethyl]-4-(1H-indol-4-yl)piperazine-1-carboxamide
C21H28N6O2 — CID 126836135
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)ethyl]-4-(1H-indol-4-yl)piperazine-1-carboxamide
N-[1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)ethyl]-4-(1H-indol-4-yl)piperazine-1-carboxamide (PubChem CID 126836135) has the molecular formula C21H28N6O2 and a molecular weight of 396.50 g/mol. Its IUPAC name is N-[1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)ethyl]-4-(1H-indol-4-yl)piperazine-1-carboxamide.
Molecular Properties
| Compound Name | N-[1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)ethyl]-4-(1H-indol-4-yl)piperazine-1-carboxamide |
|---|---|
| PubChem CID | 126836135 |
| Molecular Formula | C21H28N6O2 |
| Molecular Weight | 396.50 g/mol |
| Exact Mass | 396.23 |
| IUPAC Name | N-[1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)ethyl]-4-(1H-indol-4-yl)piperazine-1-carboxamide |
| SMILES | CC(NC(=O)N1CCN(c2cccc3[nH]ccc23)CC1)c1nc(C(C)(C)C)no1 |
| InChI | InChI=1S/C21H28N6O2/c1-14(18-24-19(25-29-18)21(2,3)4)23-20(28)27-12-10-26(11-13-27)17-7-5-6-16-15(17)8-9-22-16/h5-9,14,22H,10-13H2,1-4H3,(H,23,28) |
| InChIKey | YTZCJZRYYHLVFO-UHFFFAOYSA-N |
| XLogP | 3.44 |
| TPSA | 90.29 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 396.50 |
| LogP ≤ 5 | 3.44 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126836135 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.